Chief Executive Officer

Chief Financial Officer

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

In Brief This Week: GeneDx, Revvity, Geneyx Genomex, Omics Discoveries

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

GeneDx granted breakthrough device designation for whole genome, exome tests

Associate Director, Denials and Appeals

GeneDx is a company that delivers personalized health insights to inform diagnosis and improve drug discovery. The Associate Director, Claims and Denials is responsible for leading the claims follow-up and denials management functions, ensuring timely resolution of claims and improving reimbursement outcomes.

Head of People

Talent Acquisition Lead

Senior Vice President, Payer Relations and Reimbursement

Sign up with Google

Sign in with Google